Published in Tech Coloproctol on August 05, 2014
Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit. World J Gastroenterol (2016) 0.75
Functional bowel disorders. Gastroenterology (2006) 20.72
The functional gastrointestinal disorders and the Rome III process. Gastroenterology (2006) 8.71
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology (2007) 5.04
Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol (2001) 4.11
A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med (2008) 3.91
Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol (2002) 3.43
Defecation frequency and timing, and stool form in the general population: a prospective study. Gut (1992) 3.17
Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol (2005) 3.10
A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum (1996) 2.87
Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther (2007) 2.79
Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology (2010) 2.36
Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut (2008) 2.16
Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol (2010) 2.12
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
American Gastroenterological Association technical review on the diagnosis and treatment of hemorrhoids. Gastroenterology (2004) 1.95
Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces. Appl Environ Microbiol (1996) 1.93
Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther (2010) 1.80
Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol (2009) 1.54
What is the meaning of colorectal transit time measurement? Dis Colon Rectum (1992) 1.39
Unbalance of intestinal microbiota in atopic children. BMC Microbiol (2012) 1.37
Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol (2003) 1.36
Psyllium as therapeutic and drug delivery agent. Int J Pharm (2007) 1.34
Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol (2001) 1.29
Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation. J Psychosom Res (2007) 1.22
Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab (2002) 1.16
The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutr J (2007) 1.14
Dyssynergic defecation. Gastroenterol Clin North Am (2001) 1.13
Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol (2010) 1.10
Gastrointestinal effects of prebiotics. Br J Nutr (2002) 1.08
Rectal intussusception in symptomatic patients is different from that in asymptomatic volunteers. Br J Surg (2005) 0.99
Selective carbohydrate utilization by lactobacilli and bifidobacteria. J Appl Microbiol (2013) 0.96
Depression in first generation labour migrants in Western Europe: the utility of the Center for Epidemiologic Studies Depression Scale (CES-D). Int J Geriatr Psychiatry (2004) 0.95
Synbiotics in health and disease. Annu Rev Food Sci Technol (2011) 0.90
Effects of a meal and bisacodyl on colonic motility in healthy volunteers and patients with slow-transit constipation. Dig Dis Sci (2003) 0.90
Fermentation properties of gentio-oligosaccharides. Lett Appl Microbiol (2001) 0.90
Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. BMC Microbiol (2012) 0.89
Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms. Acta Biomed (2007) 0.86
The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? Mol Nutr Food Res (2010) 0.86
A comparison of stool characteristics from normal and constipated people. Dig Dis Sci (1998) 0.84
Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study. J Gastroenterol Hepatol (2013) 0.84
Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria. Appl Environ Microbiol (2011) 0.80
Targeting enteric neuroplasticity: diet and bugs as new key factors. Gastroenterology (2010) 0.77
Illness behavior, affective disturbance and intestinal transit time in idiopathic constipation. J Psychosom Res (1997) 0.76
The diagnosis of abnormal illness behaviour. Aust N Z J Psychiatry (1971) 0.75
Accuracy in assessment of colonic transit time with particles: how many markers should be used? Neurogastroenterol Motil (2010) 0.75
The associations between laxative abuse and other symptoms among adults with anorexia nervosa. Int J Eat Disord (2004) 0.75
Usefulness of psyllium in rehabilitation of obstructed defecation. Tech Coloproctol (2011) 0.75
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 5.34
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation (2000) 2.81
Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther (1999) 2.26
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol (2008) 1.61
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo. Cancer Res (2001) 1.56
Community health centers: promise and performance. Med Care Res Rev (1998) 1.30
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther (1999) 1.24
Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol (2002) 1.15
Characterization of the plasmid pMB1 from Bifidobacterium longum and its use for shuttle vector construction. Res Microbiol (1996) 1.12
Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study. Eur J Clin Microbiol Infect Dis (2008) 1.10
Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. J Appl Microbiol (2007) 1.09
Nucleotide sequence, expression and transcriptional analysis of the Bifidobacterium longum MB 219 lacZ gene. Arch Microbiol (2001) 1.07
Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res (2001) 1.02
Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol (2002) 0.99
Synthesis and antimicrobial activity of some new benzodifurans and phenanthrolines. Boll Chim Farm (1989) 0.94
Evaluation of the rrn operon copy number in Bifidobacterium using real-time PCR. Lett Appl Microbiol (2004) 0.93
New shuttle vector for cloning in Bacillus stearothermophilus. Res Microbiol (1994) 0.92
Cortical and subcortical motor mapping in rolandic and perirolandic glioma surgery: impact on postoperative morbidity and extent of resection. J Neurosurg Sci (2007) 0.92
Improved cloning vectors for Bifidobacterium spp. Lett Appl Microbiol (1998) 0.91
Review--antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach. Eur Rev Med Pharmacol Sci (2000) 0.91
Characterization and molecular cloning of Bifidobacterium longum cryptic plasmid pMB1. Lett Appl Microbiol (1990) 0.89
Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. Eur J Pharm Biopharm (2000) 0.87
Structural organization of pBC1, a cryptic plasmid from Bacillus coagulans. J Bacteriol (1992) 0.86
Cortical areas involved in Arabic number reading. Neurology (2008) 0.85
A probiotics-containing biscuit modulates the intestinal microbiota in the elderly. J Nutr Health Aging (2013) 0.82
Relationship between age and anterograde refractoriness of the accessory pathway in Wolff-Parkinson-White patients. Cardiology (1989) 0.82
Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. Am J Cardiol (2001) 0.82
Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina. J Appl Microbiol (2004) 0.81
Antimicrobial susceptibility of Bifidobacterium. Ann Microbiol (Paris) (1983) 0.80
Characterization of gram-positive broad host-range plasmids carrying a thermophilic replicon. Res Microbiol (1991) 0.80
Effects of alpha, beta and gamma recombinant interferons on CEA production from HT-29 human colon adenocarcinoma cell line. J Biol Regul Homeost Agents (1988) 0.79
Long-term inhibition of glioma growth by systemic administration of human PEX. J Neurosurg Sci (2003) 0.78
Influenza A (H1N1) encephalitis with severe intracranial hypertension. Minerva Anestesiol (2010) 0.78
RFLP- and RAPD-based genetic relationships of seven diploid species of Avena with the A genome. Genome (1999) 0.77
[Amidine derivatives of 9H-fluorene]. Farmaco Sci (1982) 0.75
Development of a high-performance affinity chromatography-based method to study the biological interaction between whole micro-organisms and target proteins. Lett Appl Microbiol (2010) 0.75
Synthesis and antimicrobial activity of aromatic dicarboxaldehydes. Pharmazie (1990) 0.75
Effects of training on the electrophysiologic properties of atrium and accessory pathway in athletes with Wolff-Parkinson-White syndrome. Cardiology (1990) 0.75
Synthesis and antimycotic activity of some benzyloxyimino compounds. Pharmazie (1987) 0.75
Effects of propafenone on directly measured sinoatrial conduction time. Arzneimittelforschung (1988) 0.75
On the antimicrobial activity of some new poly[2,6-bis(methyleneaminomethyl)-4-methyl]phenols and their N-iodoethylated salts. Farmaco Sci (1985) 0.75
Urease activity in gastrointestinal tract of rabbit and electrophoretic behaviour of urease. Ann Inst Pasteur Microbiol (1988) 0.75
Synthesis and antimicrobial activity of some N-monosubstituted 2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamides. Pharmazie (1988) 0.75
Effect of right atrial stimulation on both atrial pressure and atrial natriuretic peptide release in essential hypertension. Cardiology (1991) 0.75
Protoplast formation and regeneration in Bifidobacterium. Microbiologica (1986) 0.75
Wavelength index at three atrial sites in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (1995) 0.75
[Hydrazines containing 1H-indene units]. Farmaco Sci (1983) 0.75
[Synthesis and antibacterial activity of azomethino and aminomethyl derivatives of 2,7-dimethoxyquinolin-3-carboxaldehyde]. Boll Chim Farm (1985) 0.75
[Atrial electrophysiologic properties in paroxysmal atrial fibrillation. Study conducted with the stimulation of 5 atrial sites]. G Ital Cardiol (1989) 0.75
Cosmetic preservation and structure-activity relationships of 4-diazo-pyrazole-5-carboxamides. Int J Cosmet Sci (1995) 0.75
[Changes in myocardial Tc-99m-sestamibi uptake in asynergic territories during low-dose echo-dobutamine test]. G Ital Cardiol (1996) 0.75
[Microbiological aspects in the formulation and production of a cosmetic]. Farmaco Prat (1982) 0.75
Synthesis, antibacterial activity and structure-activity relationships of N-substituted 3-methyl-4-diazo-5-pyrazolecarboxamides. Arzneimittelforschung (1989) 0.75